The retina, as part of the central nervous system, may reflect early signs of brain disorders like schizophrenia.

Authors defined metabolic syndrome as “the set of factors that increase the risk of cardiovascular disease and diabetes, such ...

A new event called SightLine and a series on adoption, implementation, integration (AII) draw the attention of ophthalmic ...

This device is known as Oz, which stimulates the cells of the retina in a specific way to see colors differently. A color "more saturated than any color you can see in the real world," according ...

In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion. The FDA issued a complete response ...

Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight ... by the loss of photoreceptors and retinal pigment epithelial (RPE ...

Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy (GA), based on feedback from the EU regulator. It is a major ...

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

One of Astellas’ projects is a study looking at a stem-cell-based treatment for geographic atrophy — an advanced form of age-related macular degeneration, which is when the part of retina ...

Abby Markward, MBA, is Executive Director of the ASCRS Foundation and the ASOA, and she sat down with the Eye Care Network to preview the ASOA's first foray into the retina space. This transcript has ...